Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utilization of Robotic EksoSkeleton to Achieve High Dosing, Intensity, and Complexity of Gait in Treatment of People With Parkinson's Disease

NCT06225830 is registered in ClinicalTrials.gov with Albert Einstein Healthcare Network as lead sponsor.

NCT NCT06225830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06225830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utilization of Robotic EksoSkeleton to Achieve High Dosing, Intensity, and Complexity of Gait in Treatment of People With Parkinson's Disease
Lead sponsor
Albert Einstein Healthcare Network
Phase
Not applicable
Overall status
Completed
Start date
June 4, 2024
Completion date
August 24, 2026
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease